Hexamer Therapeutics Inc.

Pullman, WA Doing business as Hexamer Therapeutics Inc. Hexamer Therapeutics

UEI
MK8HSFMVB647
CAGE
9CUB9
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
2345 NE Hopkins Ct b, Pullman, WA 99163, USA
Website
hexamertherapeutics.com
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Hexamer Therapeutics Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Research and development services BA230121 titled self assembling vaccine platform Contract · HT942523C0078 Defense Health Agency $3,928,061

Quick answers

What is Hexamer Therapeutics Inc.'s UEI?

Hexamer Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is MK8HSFMVB647.

What is Hexamer Therapeutics Inc.'s CAGE code?

Hexamer Therapeutics Inc.'s CAGE code is 9CUB9.

What is Hexamer Therapeutics Inc.'s primary NAICS code?

Hexamer Therapeutics Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Hexamer Therapeutics Inc. located?

Hexamer Therapeutics Inc.'s physical address in SAM.gov is 2345 NE Hopkins Ct b, Pullman, WA 99163, USA.

Is Hexamer Therapeutics Inc. registered in SAM.gov?

Yes. Hexamer Therapeutics Inc.'s SAM.gov registration is active through July 7, 2027.

What is Hexamer Therapeutics Inc.'s most recent federal award?

Hexamer Therapeutics Inc.'s most recent federal contract award is Research and development services BA230121 titled self assembling vaccine platform (HT942523C0078), from Defense Health Agency, on September 29, 2023.

On GovTribe

See Hexamer Therapeutics Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors